Canada Markets closed

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
63.74+0.34 (+0.54%)
At close: 05:42PM CEST
Full screen
Previous Close63.40
Open63.73
Bid63.81 x 28400
Ask63.83 x 2100
Day's Range63.69 - 64.55
52 Week Range43.90 - 67.99
Volume2,625,237
Avg. Volume4,107,836
Market Cap62.62B
Beta (5Y Monthly)1.19
PE Ratio (TTM)424.93
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.00 (3.31%)
Ex-Dividend DateMay 02, 2022
1y Target EstN/A
  • Zacks

    Regeneron's (REGN) Evkeeza Positive in Late-Stage Study

    Regeneron (REGN) announces positive data on a phase III study on cholesterol treatment Evkeeza.

  • Bloomberg

    Crypto Growing in Latin America Adoption: New Economy Update

    (Bloomberg) -- Can Latin America seize the opportunities in front of it stemming from supply chain disruptions, cheap labor and a growing technology industry in order to revert a decade of tepid growth? Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightChina in Talks With Russia to Buy Oil for Strategic ReservesApple Shows AR/VR Headset to Board in Sign of Progress on Key Project Elon Musk Gets Defensive Over Twitter Meme as Harassment

  • Zacks

    Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update

    Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.